
Finasteride
Hormonal pathway
Targets an important hormonal pathway involved in male-pattern hair loss.
Explore finasteride →Compare hair loss treatments
Different treatments. Different pathways.
Finasteride and minoxidil are two established approaches to hair loss, but they work differently. Understanding those differences can help you have a better conversation with your physician about which treatment approach may be appropriate.
$29 physician visit · 100% online · Board-certified physicians · Personalized care
Prescription treatment requires physician evaluation and clinical appropriateness. Medication costs are separate.

The short answer
Targets an important hormonal pathway involved in male-pattern hair loss by inhibiting 5-alpha-reductase and reducing DHT.
Supports hair growth through a different, non-DHT-suppression mechanism.
Finasteride targets a major driver of androgenetic hair loss. Minoxidil supports the growth side of the equation through a different mechanism. DHT is a major contributor to male-pattern hair loss, but it is not the only reason hair changes — and minoxidil's complete mechanism in hair growth is not fully established. That is part of why these medications are considered differently for different patients.
So the useful question usually isn't “which one wins?”
It's “what is actually driving my hair loss, and which approach fits my health?”
Let a physician help me choose →At a glance
This comparison is educational, not a ranking, and it does not indicate that either medication is appropriate for you. Specific indications, dosing and safety information appear in the FDA-approved prescribing information for any product prescribed to you and should be discussed with your physician.
DHT
Inhibits 5-alpha-reductase → reduces DHT formation
Testosterone is converted to dihydrotestosterone (DHT) by the enzyme 5-alpha-reductase. In people with a genetic sensitivity to it, DHT is associated with the progressive miniaturization of susceptible scalp follicles that characterizes androgenetic hair loss.
Finasteride acts on that enzyme, reducing DHT formation. That is why it is described as addressing a driver of pattern hair loss rather than stimulating growth directly.
Works through a different pathway
Minoxidil is understood to act at the hair follicle and on the hair-growth cycle rather than on hormones. It does not primarily treat hair loss by reducing DHT.
Its precise mechanism in hair growth is not completely established, and it should not be described with more certainty than the evidence supports.
Testosterone
5-alpha-reductase
DHT
Susceptible hair follicles
Progressive miniaturization
If a hormonal pathway is contributing to your hair loss, a treatment that acts on that pathway addresses something different than a treatment that supports growth at the follicle. That's why these two medications are not interchangeable versions of the same idea — and why the right approach depends on what a physician finds when they evaluate you.
The question everyone asks
There is no universal winner, and any site that gives you one is selling something. Both are established approaches with different mechanisms, different regulatory status by formulation and different safety considerations. Comparative studies exist in the dermatology literature, but they examine specific populations, formulations and endpoints — which is exactly why their results cannot be turned into a blanket statement about which medication is better for you. What matters clinically is the type of hair loss you have, whether a hormonal driver is involved, and what is medically appropriate given your health.
The better treatment is the one that appropriately addresses your hair loss and fits your medical situation.
Treatment goals
Many people assume hair-loss treatment only “works” if dramatic new hair appears. Clinically, that isn't how goals are usually set. Hair loss is progressive, so preventing further loss is a meaningful outcome in its own right — and for some patients it is the most realistic one. Your physician can explain which goals may be reasonable in your situation. None of these outcomes is guaranteed for any individual.
Treatment may aim to slow the pace at which hair loss continues, so what you have today holds longer than it otherwise would.
Protecting active follicles is often the primary goal, particularly earlier in the process when more hair remains to protect.
Some patients notice improvement in growth or density. This varies between individuals and between treatments, and cannot be promised in advance.
NORBU MD does not publish before-and-after imagery or promise regrowth. Individual results vary, some patients notice little or no change, and hair loss can have causes that neither of these medications is the right answer for. Any outcome discussion should happen with a physician who has evaluated you.
Not losing more hair is a real result — even when it doesn't photograph well.
Combination approach
Because finasteride and minoxidil work through different mechanisms, a physician may consider treatment approaches that include both for certain appropriate patients. That is a clinical decision — not a default, and not an upgrade tier.
Finasteride acts on a hormonal pathway; minoxidil supports growth through a different one. Because they are not doing the same thing, they are not necessarily alternatives to each other.
What that does not mean
It does not mean combination treatment is always superior, appropriate for everyone, or something to start on your own. More medication is not automatically better medicine.
Whether one treatment, another, both or neither makes sense depends on your evaluation — your pattern of loss, medical history, other medications and tolerability.
What to do with this
Bring the question to your visit. Your physician can explain what is reasonable for you and how treatment would be monitored.
This page does not provide dosing instructions, and NORBU MD does not market a combined finasteride/minoxidil product. Any medication regimen — single or combined — is set by your physician and described in the FDA-approved prescribing information for the specific products prescribed to you.
Discuss my treatment options →Tolerability
These medications do not share a safety profile, and neither is universally “safer” than the other. Finasteride is a systemic hormonal treatment with its own warnings. Minoxidil's considerations depend heavily on whether it is applied topically or taken orally — a distinction that matters more than most comparisons acknowledge.
Local scalp effects such as irritation, itching, dryness or flaking, and unwanted hair growth in areas of unintended contact. Increased shedding can occur early in treatment.
A systemic medication with different considerations, including cardiovascular and blood-pressure-related effects, fluid retention, swelling, rapid heartbeat and generalized unwanted hair growth. Requires physician prescribing and monitoring, and is off-label for hair loss.
These are not complete lists of possible adverse effects. Individual tolerability varies, and the full warnings, precautions and contraindications appear in the FDA-approved prescribing information for any product prescribed to you. Report any side effect to your physician rather than stopping or changing treatment on your own.
Topical and oral minoxidil are not the same safety conversation
Topical minoxidil's considerations are largely local to the scalp. Oral minoxidil is a systemic medication that was approved for severe hypertension in specific circumstances, carries cardiovascular and blood-pressure-related considerations, and is used off-label for hair loss. They should never be treated as having the same safety profile.
Pregnant women should not handle crushed or broken finasteride tablets because of the risk to a male fetus. Tell any clinician who orders a PSA test that you take finasteride, since it can lower PSA levels. For oral minoxidil, tell your physician about your blood pressure, heart history, kidney function and every medication you take — including other blood-pressure medications — and seek prompt medical attention for chest pain, rapid heartbeat, significant swelling, sudden weight gain or difficulty breathing. Sudden, patchy or rapidly progressing hair loss should be evaluated rather than self-treated.
Every prescription medication has risks, warnings, contraindications and possible interactions. Review the full prescribing information for any product prescribed to you, and tell your NORBU MD physician about all medications, supplements and health conditions before starting or changing treatment. Seek medical care promptly for any symptom that concerns you.
Personalized care
Sexual adverse effects have been reported with finasteride, including decreased libido, erectile dysfunction and ejaculatory disorders. That concern is legitimate and worth raising directly. It should not be dismissed, and it should not be exaggerated either — most men prescribed finasteride do not report these effects, but some do, and reports of symptoms persisting after discontinuation exist in the literature. No one can promise you it cannot happen, or that every symptom resolves if treatment stops. If this matters to you, say so during your visit. It belongs in the treatment decision, not after it. Beyond that, choosing between these treatments is really a clinical evaluation, and a physician has a list of things to work through before a medication is even on the table.
You don't need to decide between finasteride and minoxidil before seeing a physician.
Important distinction
Comparisons of finasteride and minoxidil often skip the fact that minoxidil isn't one treatment decision. Topical and oral minoxidil differ in route, regulatory status, prescription requirements and safety considerations.
Applied to the scalp. Certain topical products are FDA-approved for specified hair-loss indications, and some formulations are available without a prescription.
A systemic medication taken by mouth. It is FDA-approved for severe hypertension under specific circumstances; use for hair loss is off-label, requires physician prescribing, and carries different systemic considerations.
“Finasteride vs. minoxidil” is a different comparison depending on which minoxidil you mean — including whether a prescription and blood-pressure review are part of the conversation at all.
Off-label prescribing is legal and common in medicine, but it means the FDA has not evaluated that specific use. Your physician should tell you when a treatment is being considered off-label.
Nothing on this page is dosing guidance. Which formulation, if any, may be appropriate for you is a physician decision based on your evaluation.
Let's make it personal
$29Physician visit
For $29, meet online with a licensed NORBU MD physician to discuss your hair loss, health history and which treatment options may be appropriate.
100% online · Board-certified physicians · Personalized care · Ongoing support
The $29 fee covers the physician visit. Medication, laboratory testing or other services, if applicable, are separate.
Tell us what you've noticed
Meet your physician online
Discuss your options
Start a personalized treatment plan if clinically appropriate

Hormonal pathway
Targets an important hormonal pathway involved in male-pattern hair loss.
Explore finasteride →
A different pathway
Supports hair growth through a different treatment pathway, available as topical or oral formulations.
Explore minoxidil →Questions
Finasteride inhibits 5-alpha-reductase and reduces DHT, a hormone associated with male-pattern hair loss. Minoxidil supports hair growth through a different mechanism that does not primarily involve DHT suppression. They are not competing versions of the same medication.
Neither is universally better. Which may be appropriate depends on the type and cause of your hair loss, your medical history, tolerability, formulation and physician judgment.
Not as a blanket statement. Finasteride addresses a hormonal driver of androgenetic hair loss, which is relevant when that driver is involved. Comparative studies exist but examine specific populations and formulations, and their results do not translate into a universal ranking.
Also not as a blanket statement. Minoxidil is used for certain forms and patterns of hair loss, and topical formulations are available without a prescription — but it does not address the hormonal pathway that finasteride targets.
Finasteride. It inhibits 5-alpha-reductase, the enzyme that converts testosterone to DHT. Minoxidil works through a different pathway and does not primarily treat hair loss by reducing DHT.
Neither can be promised to regrow hair for any individual. Both are used with the goal of slowing loss and supporting the hair you still have, and some patients notice improvement in growth or density. Outcomes vary and depend on the cause and stage of your hair loss.
Both are used with maintenance in mind, through different mechanisms. Where a hormonal driver is involved in pattern hair loss, addressing that pathway is part of why finasteride is commonly considered. Your physician can explain what is realistic for you.
Hair grows in cycles, so response to any hair-loss treatment is generally evaluated over months rather than weeks, with consistent use as directed. Your physician can tell you when to expect a meaningful review.
The same principle applies. Minoxidil is used consistently over time, and treatment is assessed over months. Some people notice temporary increased shedding early on.
For certain appropriate patients, a physician may consider a treatment approach that includes both, because the medications work through different mechanisms. That is a clinical decision — combination treatment is not automatically better and should never be started on your own.
Treatment-related benefits generally depend on continued use. If treatment stops, hair loss typically resumes its previous course over time. Whether ongoing treatment makes sense for you is worth discussing with your physician.
DHT levels return toward their prior state and hair loss generally resumes its previous course. Any hair maintained because of treatment is typically lost over time after stopping.
Treatment-related changes generally fade after discontinuation, and hair loss typically resumes its prior course. Consistency is part of why treatment is a long-term decision rather than a trial.
Sexual adverse effects have been reported with finasteride, including decreased libido, erectile dysfunction and ejaculatory disorders. Most men prescribed finasteride do not report them, but some do, and reports of symptoms persisting after discontinuation exist. No one can promise these effects cannot happen or that every symptom resolves after stopping. Raise the concern during your visit.
Finasteride acts on the conversion of testosterone to DHT rather than being a testosterone treatment. Hormonal effects and how they may apply to you should be discussed with your physician.
Topical minoxidil is applied to the scalp, and certain products are FDA-approved for specified hair-loss indications with some available over the counter. Oral minoxidil is systemic, requires a prescription, and carries different considerations including cardiovascular and blood-pressure-related effects.
No. Oral minoxidil is FDA-approved for severe hypertension in specific circumstances. Use for hair loss is off-label, which means the FDA has not evaluated that specific use.
Oral minoxidil is a blood-pressure medication by approved indication, so cardiovascular and blood-pressure-related considerations are part of why it requires physician prescribing and monitoring. Tell your physician about your heart history and all medications you take.
Neither is universally safer. The profiles are different: finasteride is a systemic hormonal treatment with its own warnings, topical minoxidil's effects are largely local to the scalp, and oral minoxidil carries systemic considerations. They should be compared individually, with your health in the picture.
Finasteride requires a prescription. Certain topical minoxidil products are available over the counter, while oral minoxidil requires a prescription. A physician evaluation is worthwhile either way, so the cause of your hair loss is properly assessed.
The physician visit is $29. It covers your online visit with a licensed NORBU MD physician, including discussion of your hair loss, health history and treatment options.
No. The $29 fee covers the physician visit only. Medication, laboratory testing and other services, if applicable, are separate.
Yes. You can raise finasteride, topical minoxidil, oral minoxidil and combination approaches in the same visit, and your physician can explain which options may be appropriate given your health.
This page is educational and is not medical advice. Always review the FDA-approved prescribing information for any specific product prescribed to you and discuss your care with a board-certified physician.

The hormonal pathway behind androgenetic hair loss — and why only one of these treatments targets it.
Education

5-alpha-reductase, DHT and what treatment can reasonably be expected to do.
Treatment guide

Same molecule, different treatment decision — regulatory status, prescribing and safety all differ.
Treatment guide

What has been reported, what isn't known, and why it belongs in the treatment decision.
Safety

Different mechanisms can complement a strategy — but more medication isn't automatically better medicine.
Comparison guide

Why hair biology is measured in cycles, and what consistency has to do with evaluating response.
Expectations

Benefits generally depend on continued use — here's what that means in practice.
Expectations

Pattern, timeline and contributing factors decide which pathway your treatment should target.
4 min read
Meet online with a NORBU MD physician and discuss which hair-loss treatment options may be appropriate for you.